SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-011268
Filing Date
2017-12-04
Accepted
2017-12-04 09:44:31
Documents
2
Period of Report
2017-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT azrx8k_dec42017.htm 8-K 28951
2 PRESS RELEASE DATED DECEMBER 4, 2017 azrx_ex99-1.htm EX-99.1 9886
  Complete submission text file 0001654954-17-011268.txt   40011
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 171235929
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1